— Know what they know.
Not Investment Advice

CDXC NASDAQ

ChromaDex Corporation
1W: +9.2% 1M: -21.7% 3M: +16.7% 1Y: +50.1% 3Y: +148.6% 5Y: +76.4%
$7.87
Last traded 2025-04-14 — delisted
NASDAQ · Healthcare · Biotechnology · $611.9M mcap · 51M float · 1.59% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
$14M +11.5% ▲
Capital Expenditures
$292K -79.1% ▼
5Y CAGR: +15.5%
Free Cash Flow
$13M +10.6% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$251K +0.0% ▲
Net Change in Cash
$20M +16.1% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income-$27M-$17M-$5M$9M$17M
Depreciation & Amort.$2M$2M$2M$814K$785K
Stock-Based Comp.$6M$6M$5M$4M$6M
Change in Working Capital-$4M-$6M$5M$3M$0
Other Non-Cash Items-$711K-$167K$1M-$4M-$11M
Operating Cash Flow-$24M-$15M$7M$12M$14M
— Investing Activities —
Capital Expenditures-$409K-$334K-$148K-$163K-$292K
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0$5K$20K$0
Investing Cash Flow-$409K-$334K-$143K-$143K-$292K
— Financing Activities —
Net Debt Issuance-$31K-$16K-$15K-$11K$0
Stock Repurchased$0$0$0$0-$251K
Dividends Paid$0$0$0$0$0
Other Financing$9M-$77K-$75K$5M$7M
Financing Cash Flow$36M$8M-$90K$5M$7M
Net Change in Cash$12M-$8M$7M$17M$20M
Cash End of Period$28M$20M$27M$45M$65M
Free Cash Flow-$25M-$15M$7M$12M$13M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms